BioLife Solutions, Inc. reaffirmed 2023 revenue guidance for the fiscal 2023. For the period, the company expects revenue to range from $188 million to $202 million, reflecting year-over-year growth of 16% to 25%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.2 USD | -1.66% | -0.49% | +24.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.31% | 931M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- BLFS Stock
- News BioLife Solutions, Inc.
- Biolife Solutions, Inc. Reaffirms 2023 Revenue Guidance for the Fiscal 2023